中文版
Home
About us
Company Profile
Culture
Join Us
Contact Us
Products
Marketed Vaccine
R&D vaccine
R&D
R&D Overview
Research achievements
International
International project
Overseas market
International certificate
News
Company news
Industry news
Latest announcement
Home
About us
Company Profile
About Us
Enterprise Honor
Development history
Culture
Cultural concept
Staff presence
Social responsibility
Join Us
Join Us
Talent concept
Well-paid job
Contact Us
Products
Marketed Vaccine
SARS-COV-2 VACCINE(VERO CELL), INACTIVATED
Recombinant Hepatitis B Vaccine (10μg/20μg/60μg)
23-Valent Pneumococcal Polysaccharide Vaccine
Diphtheria Tetanus Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine
Haemophilus Influenzae Type b Conjugate Vaccine
Measles and Rubella Combined Vaccine ,Live
R&D vaccine
13-Valent Pneumococcal Conjugate Vaccine
Rabies vaccine (human diploid cell) for human use, Freeze-dried
Inactivated Poliomyelitis Vaccine, Sabin Strains
Hib Conjugate Vaccine, Freeze-dried
Service
Vaccine science
Information disclosure
R&D
R&D Overview
Scientific payoffs
R&D Project
International
Cooperative project
International exchange
International certificate
GMP Certificate
Products Certificate
Overseas market
Investor relations
Corporate Governance
Company announcements
Shareholder Returns
Stock quotation
Investor Online
Investors contact
News
Company news
Industry news
Latest announcement
中文版
Home
>
News
>
Products
Marketed Vaccine
R&D Vaccine
13-Valent Pneumococcal Conjugate Vaccine
MORE >
Rabies vaccine (human diploid cell) for human use, Freeze-dried
MORE >
Inactivated Poliomyelitis Vaccine, Sabin Strains
MORE >
Hib Conjugate Vaccine, Freeze-dried
MORE >
0755-26988688